Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.8.0.1
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2017
Accounting Policies [Abstract]  
Schedule of Effect of Adoption of ASC Topic 606 on Condensed Consolidated Balance Sheet and Statement of Operations

The following tables present the effect of the adoption of ASC Topic 606 on our condensed consolidated balance sheet and revenue as of and for the three months ended March 31, 2018:

 

Consolidated Balance Sheet:                  
    March 31, 2018  
          (unaudited)        
    As reported     Balances without Adoption of ASC 606     Effect of Change
Higher/(Lower) 		 
Accounts receivable, net   $ 6,403     $ 4,828     $ 1,575  
Accumulated deficit     (132,493 )     (134,993 )     (2,500 )

 

Revenue:                  
    For the three months ended March 31, 2018  
          (unaudited)        
    As reported     Balances without Adoption of ASC 606     Effect of Change
Higher/(Lower) 		 
Revenue, net   $ 4,809     $ 4,409     $ 400

Schedule of Other Current Assets

Other current assets consisted of the following as of March 31, 2018 and December 31, 2017:

 

    March 31, 2018     December 31, 2017  
    (unaudited)        
             
Indemnification asset   $ 875     $ 875  
Prepaids     177       266  
Other     40       31  
    $ 1,092     $ 1,172

Schedule of Weighted Average Number of Shares

A reconciliation of the number of shares of common stock used in the calculation of basic and diluted income (loss) per share for the three-month periods ended March 31, 2018 and 2017 is as follows:

 

    Three Months Ended  
    March 31,  
    2018     2017  
    (unaudited)  
Basic weighted average number of common shares     27,855       4,294  
Potential dilutive effect of stock-based awards     -       90  
                 
Diluted weighted average number of common shares     27,855       4,384  

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following outstanding stock-based awards were excluded from the computation of the effect of dilutive securities on (loss) income per share for the following periods because they would have been anti-dilutive:

 

    Three Months Ended  
    March 31,  
    2018     2017  
    (unaudited)  
Options     2,256       -  
Stock-settled stock appreciation rights (SARs)     84       85  
Restricted stock and restricted stock units (RSUs)     220       -  
Warrants     13,542       955  
      16,102       1,040